Status: Not yet recruiting
Biomarker Testing to Predict Radiation-Related Heart Disease in Lung Cancer Patients
The study will measure serum Pro-N-Cadherin and NT-proBNP (pro B-type natriuretic peptide) levels in adults with non-small cell lung cancer receiving hypofractionated radiation therapy and evaluate whether these biomarkers correlate with radiation dose to the heart, cardiac dysfunction, and adverse cardiac events. Participants will undergo blood collection and echocardiography over a two-year follow-up period.
Participants needed: 50
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: Duke UniversityUpdated: Oct 9, 2026Locations: 1
Eligibility criteria
≥ 18 years of age [+5]
Planning to receive concurrent or sequential chemotherapy or immunotherapy [+1]